Abstract
TNF-α has been clearly identified as central mediator of T cell activation-induced acute hepatic injury in mice, e.g., Con A hepatitis. In this model, liver injury depends on both TNFRs, i.e., the 55-kDa TNFR1 as well as the 75-kDa TNFR2. We show in this report that the hepatic TNFRs are not transcriptionally regulated, but are regulated by receptor shedding. TNF directly mediates hepatocellular death by activation of TNFR1 but also induces the expression of inflammatory proteins, such as cytokines and adhesion molecules. Here we provide evidence that resistance of TNFR1−/− and TNFR2−/− mice against Con A hepatitis is not due to an impaired production of the central mediators TNF and IFN-γ. Con A injection results in a massive induction of ICAM-1, VCAM-1, and E-selectin in the liver. Lack of either one of both TNFRs did not change adhesion molecule expression in the livers of Con A-treated mice, presumably reflecting the fact that other endothelial cell-activating cytokines up-regulated adhesion molecule expression. However, treatment of TNFR1−/− and TNFR2−/− mice with murine rTNF revealed a predominant role for TNFR1 for the induction of hepatic adhesion molecule expression. Pretreatment with blocking Abs against E- and P-selectin or of ICAM−/− mice with anti-VCAM-1 Abs failed to prevent Con A hepatitis, although accumulation of the critical cell population, i.e., CD4+ T cells was significantly inhibited. Hence, up-regulation of adhesion molecules during acute hepatitis unlikely contributes to organ injury but rather represents a defense mechanism.
Tumor necrosis factor-α is a pleiotropic cytokine that mediates host defense as well as tumor necrosis. TNF is able to induce profound changes of the vascular endothelium. These mechanisms are likely to contribute to tissue injury in pathology such as disseminated intravascular coagulation seen in septic shock, adult respiratory distress syndrome, or cerebral malaria. The central role for TNF in up-regulating cell surface adhesion molecules such as ICAM-1, VCAM-1, or E-selectin, thereby promoting adhesion of leukocytes to and subsequent transmigration through the endothelial barrier, is well documented (1, 2).
TNF exerts its actions via two distinct surface receptors, the 55-kDa receptor (also termed TNFR1 or TNFR p55) and the 75-kDa receptor (TNFR2 or TNFR p75) (3). The biological actions of TNFR1 have been extensively studied (4, 5), whereas the role for TNFR2, which preferentially binds the 26-kDa membrane-bound (m)3 precursor form of soluble (s) TNF (6), is not completely understood. A previous report emphasized the in vivo relevance of TNFR2 by showing that mTNF-induced adhesion molecule expression via TNFR2 was inhibited in mice lacking this receptor (TNFR2−/−), but not in mice lacking TNFR1 (TNFR1−/−), thereby inducing resistance against experimental induced cerebral malaria (7).
In addition there is increasing evidence that acute or chronic liver disease is closely related to elevated TNF and TNFR (sTNFRs) plasma levels as well as to a strong induction of in situ expression of both TNFRs (8, 9, 10, 11). The direct hepatotoxic effect of TNF has been studied in various experimental T cell- and macrophage-dependent models (12). We recently described a CD4+ T cell, TNF (13) and IFN-γ-dependent (14) model of liver injury in mice, which is inducible by a single injection of the mitogenic plant lectin Con A (15). The 26-kDa membrane-bound precursor form of 17-kDa sTNF and both TNFRs have been shown to be central for the development of Con A hepatitis (16). Additional mediators such as the Fas ligand/Fas system or perforin/granzyme have been described either to contribute (17, 18) or not to contribute (19, 18) to liver injury induced by Con A. However, mTNF-, Fas ligand-, and perforin-mediated direct hepatotoxic effects require cell-to-cell contact between hepatocytes and leukocytes. A prerequisite for the direct action of effector cells is their adhesion to and transmigration through the endothelial barrier. The protective effect of anti-ICAM-1 mAbs (18) and Arg-Gly-Asp mimetics (which block binding of β1 integrins to several extracellular matrix glycoproteins) (20) from Con A hepatitis confirmed this assumption.
Therefore, we designed a study, which had the objective to characterize the TNFR-dependent expression of adhesion molecules in Con A hepatitis and to evaluate the functional role of adhesion molecule up-regulation for Con A-induced CD4+ T cell recruitment and liver damage.
Materials and Methods
Mice
Male BALB/c and ICAM−/− mice were obtained from the institute’s internal animal breeding house. TNFR−/− mice were kindly provided by Dr. H. Bluethmann (Hoffmann LaRoche AG, Basel, Switzerland). The appropriate wild-type (wt) animals were used in all experiments in which knockout mice were used. Animals received human care according to the National Institutes of Health as well as to the legal requirements in Germany and were maintained under controlled conditions (22°C, 55% humidity, 12-h dark/light cycle) and had free access to standard laboratory chow (Altromin 1313) and water. When taken into the experiment, mice were 6–8 wk old and had a half weight of 18–25 g.
Con A and murine (mu) rTNF treatment
All reagents were injected in a total volume of 200 μl per 20-g mouse. Con A (Sigma, Deisenhofen, Germany) was injected i.v. in pyrogen-free saline. The dose of Con A was 20 and 18 mg/kg in BALB/c mice and TNFR−/− mice, respectively (because of the lower sensitivity of BALB/c mice toward Con A-induced liver injury; Ref. 21). rmuTNF (kindly provided by Dr. G. R. Adolf, Bender & Co, Vienna, Austria) was injected i.v. in pyrogen-free saline in a concentration of 10 μg/kg.
In vivo neutralization of adhesion molecules
The following mAbs were dissolved in pyrogen-free saline and injected i.v. 15 min before Con A application: 1) 200 μg of rat anti-mouse E-selectin mAb (UZ4) (22), 200 μg of rat-anti-mouse P-selectin mAb (RB40.34) (23), or a combination of both; 2) 150 μg of rat anti-mouse ICAM-1 mAb (YN1/1.7.4) and 150 μg of rat anti-mouse CD11a mAb (M17/4, PharMingen, Hamburg, Germany); 3) 150 μg rat anti-mouse VCAM-1 mAb (429, PharMingen). As isotype control, we injected an anti-endothelial Ab, which does not interact with adhesion molecules (BR2). In vivo binding was controlled with immunofluorescent staining of i.v.-injected mAbs (slides were solely incubated with the Texas Red-labeled goat anti-rat secondary Ab).
Sampling of material and determination of alanine aminotransferase (ALT), cytokines, and sTNFRs
For determination of circulating cytokines (TNF and IFN-γ) and sTNFRs by ELISA (see above), blood was taken from the tail vein at the indicated time points. After lethal anesthesia, blood was taken by cardiac puncture for ALT measurement as previously described (14, 24). Liver was then removed and frozen for determination of DNA fragmentation as described elsewhere (14) or for immunofluorescent analysis (see below).
Cytokine and sTNFR determination by ELISA
Detection of TNF, IFN-γ, and IL-2 was performed as previously described (25). sTNFRs were measured using a commercial ELISA kit (Genzyme, Cambridge, MA), which was exactly performed according to the manufacturers instructions.
Abs used for immunofluorescence
As primary mAbs: YN1/1.4.7 reacts with ICAM-1, MK2/1 with VCAM-1; mAb 10E9.6 reacts with murine E-selectin; RM4-5 recognizes CD4 (both purchased from PharMingen); primary rat mAbs were detected using goat anti-rat IgG tagged with Texas Red (Dianova, Hamburg, Germany). TNFR1 and TNFR2 were detected with a polyclonal rabbit anti-mouse Ab (Hy Cult Biotechnology, Uden, The Netherlands); primary rabbit Abs were detected with Cy 3-labeled goat anti-rabbit Ab (Dianova). Clone 104 detected CD45.2 and was directly labeled with FITC (PharMingen). Mouse endothelial cell Ag 32 (MECA-32) recognizes an endothelial Ag and was used as positive, rat IgG (PharMingen) as negative control, to exclude unspecific binding of the primary Ab.
Immunofluorescent staining and confocal laser imaging
Cryostat sections were performed at 10 μm, fixed in acetone/methanol (1:1) at 4°C for 10 min. After washing in PBS, slides were blocked with PBS containing 3% BSA and then incubated overnight with the primary Ab, at 4°C in a moist, light-protected chamber. After rinsing with PBS, binding sites were detected with the secondary Ab dissolved in PBS/BSA 3% for 1 h at room temperature. After washing in PBS, slides were mounted with TBS/glycerol (1:1), pH 8.6. Sections were then examined by confocal laser scanning microscopy (Bio-Rad 1000).
Semiquantitative RT-PCR
Total liver RNA was isolated by Clontech Kit (ClonTech, Palo Alto, CA) according to the manufacturer’s instructions. Two micrograms of total liver RNA was then reverse transcribed into cDNA using the Superscript II Polymerase (Life Technologies GmbH, Eggenstein, Germany). The sequences of the oligonucleotide primers are: 5′ TNFR1, CTG CTG TCA CTG GTG CTC DTG; 3′ TNFR1, CAC ACA CCG TGT CCT TGT CAG; 5′ TNFR2, GTC GCG CTG GTC TTC GAA C; 3′ TNFR2, CAC TTG CTC AGC CTC ATG. PCR was conducted in an automatic DNA thermal cycler Primus 96 Thermocycler (MWG-Biotech, Ebersberg, Germany). The cycle program was set to anneal at 58°C for a total of 32 cycles. The expected fragment lengths were 349 bp for TNFR1 and 413 bp for TNFR2. Amplicons were visualized by agarose gel electrophoresis. The gels were scanned by GelDoc 2000 (Bio-Rad, Richmond, CA). The relative quantities of TNFR1 and TNFR2 mRNA are presented as ratio between the intensity of TNFR1 and TNFR2 band relative to the intensity of the housekeeping gene β-actin.
Cell preparations
Mice were killed by exsanguination from the subclavian artery and vein and livers were then removed. Hepatic mononuclear cells (MNCs) were prepared as previously described (26). Briefly, the liver was pressed through a stainless steel mesh and suspended in RPMI 1640 medium with 10% FCS and 25 mM HEPES. The cell suspension was centrifuged at 1200 rpm for 5 min and resuspended in 20 ml medium and then centrifuged at 50 × g for 30 s. Supernatants were resuspended in 10 ml medium and cell suspension was overlaid on 5 ml histopaque solution (density: 1083, obtained from Sigma). After centrifugation at 600 × g for 25 min at 25°C, the visible interface was aspirated and resuspended in medium to perform cell counts. Cells were washed once again and resuspended in PBS/FCS 1% to perform flow cytometry.
Flow cytometric analysis
FITC-labeled anti-CD45 (clone 104) and Texas Red-tagged anti-CD4 (clone RM4-5) were purchased from PharMingen. Cell suspensions of 105 cells were stained with mAbs and analyzed by flow cytometer (Coulter Pharmaceutical, Palo Alto, CA). Dead cells were excluded by forward sideward scatter. The number of CD4+ T cells per liver was calculated by multiplication of the percentage of CD4+ T cells with the percentage of CD45+ leukocytes of total isolated MNCs.
Statistical analysis
Data of ALT, cytokines, and sTNFRs are expressed as mean ± SEM and analyzed by one-way ANOVA; in case of differences among groups (at least p < 0.05), data were subjected to Dunnett’s multiple comparison test of the control against all other groups with the computer program INSTAT2 (GraphPad Software, San Diego, CA).
Results
TNFR1 and TNFR2 are critical for liver failure but not for cytokine production upon Con A administration to mice
Mice deficient of either one of the two TNFRs and the corresponding wt animals were i.v. injected with a dose of 18 mg/kg Con A. TNFR1−/− and TNFR2−/− mice failed to develop liver injury upon Con A injection, as assessed by determination of plasma ALT-levels (Table I). To exclude the possibility that this, also previously observed protective effect (16) was due to a reduced production of the central mediators TNF and IFN-γ, we detected TNF and IFN-γ plasma levels of TNFR−/− mice. Circulating peak concentrations of TNF (14) were significantly elevated in both, TNFR1−/− and TNFR2−/− mice (Table I). Maximum plasma levels of IFN-γ (14) were significantly elevated in TNFR1−/− mice but were comparably high to the wt in TNFR2−/− mice (Table I).
Mice lacking one of both TNF-Rs are resistant toward Con A-induced acute hepatic failurea
. | Treatment . | ALT (U/L ± SEM) . | TNF (pg/ml ± SEM) . | IFN-γ (ng/ml ± SEM) . |
---|---|---|---|---|
wt | Saline | 11 | 10 | ND |
Con A | 3485 ± 392 | 620 ± 18 | 5.3 ± 1.5 | |
TNFR1−/− | Saline | 25 | 26 | ND |
Con A | 202 ± 76* | 4484 ± 38* | 12.9 ± 3.4* | |
TNFR2−/− | Saline | 54 | 25 | ND |
Con A | 30 ± 8* | 1368 ± 70* | 5.3 ± 1.8 |
. | Treatment . | ALT (U/L ± SEM) . | TNF (pg/ml ± SEM) . | IFN-γ (ng/ml ± SEM) . |
---|---|---|---|---|
wt | Saline | 11 | 10 | ND |
Con A | 3485 ± 392 | 620 ± 18 | 5.3 ± 1.5 | |
TNFR1−/− | Saline | 25 | 26 | ND |
Con A | 202 ± 76* | 4484 ± 38* | 12.9 ± 3.4* | |
TNFR2−/− | Saline | 54 | 25 | ND |
Con A | 30 ± 8* | 1368 ± 70* | 5.3 ± 1.8 |
Male TNF-R1−/−, TNF-R2−/− and wt (C57Bl/6 × 129) mice were i.v.-injected with 18 mg/kg Con A. Plasma enzyme activity of ALT was determined 8 h after Con A administration. TNF plasma levels were measured 2 h, IFN-γ plasma levels 8 h after Con A treatment by ELISA. Data are expressed as mean values ± SEM. ∗, p ≤ 0.05 vs Con A-treated wt mice.
In situ regulation of both TNFRs after Con A injection
To investigate whether TNFRs are up-regulated within the liver after systemic Con A injection, we performed RT-PCR and subsequent semiquantitative analysis of total liver RNA. Both TNFR mRNAs were constitutively expressed in the livers of healthy mice. Injection of Con A did not significantly change overall hepatic TNFR1 (Fig. 1,A) and TNFR2 (Fig. 1,B) mRNA production during the observed time-span of 8 h. As internal control, we analyzed TNFR1 and TNFR2 mRNA production in the spleen (Fig. 1, A and B), where both receptor transcripts were significantly induced upon Con A injection. TNFR1 and TNFR2 mRNA were undetectable in TNFR1−/− and TNFR2−/− mice, respectively (Fig. 1,C). Immunofluorescent staining of both TNFRs showed constitutive expression of both TNFRs in livers of healthy mice. However, TNFR1 and TNFR2 protein decreased as early as 1 h after injection of Con A, reaching minimum expression levels at 2 to 4 h after treatment (Fig. 2). Thereafter, TNFR expression increased, reaching almost basal levels in case of TNFR1 8 h after Con A challenge (Fig. 2). The expression level of TNFR2 8 h after Con A injection was more prominent compared with the constitutive expression of saline-treated animals (Fig. 2). No staining of either TNFR1 in TNFR1−/− or TNFR2 in TNFR2−/− mice was detectable, confirming the specific binding of the Abs (data not shown).
Expression of TNFR1 and TNFR2 mRNA after Con A injection. Total liver RNA was prepared from the liver and the spleen from either saline or Con A-treated BALB/c mice and subsequently analyzed by semiquantitative RT-PCR. A represents TNFR1 and B, TNFR2 regulation. C represents specificity of the RT-PCR, as TNFR1 and TNFR2 mRNA is not detectable in the corresponding gene-deleted animals, respectively (mRNA of blood derived leukocytes stimulated for 4 h with Con A). Semiquantitative data (A) and (B) are expressed as mean values ± SEM; n = 3 at each time; ∗, p ≤ 0.05 vs saline control.
Expression of TNFR1 and TNFR2 mRNA after Con A injection. Total liver RNA was prepared from the liver and the spleen from either saline or Con A-treated BALB/c mice and subsequently analyzed by semiquantitative RT-PCR. A represents TNFR1 and B, TNFR2 regulation. C represents specificity of the RT-PCR, as TNFR1 and TNFR2 mRNA is not detectable in the corresponding gene-deleted animals, respectively (mRNA of blood derived leukocytes stimulated for 4 h with Con A). Semiquantitative data (A) and (B) are expressed as mean values ± SEM; n = 3 at each time; ∗, p ≤ 0.05 vs saline control.
Immunofluorescent staining of TNFR1 and TNFR2 and subsequent confocal laser imaging of liver sections. Male BALB/c mice were treated with 20 mg/kg Con A. Livers were removed at the indicated time and stained with either anti-TNFR1 or anti-TNFR2 polyclonal rabbit anti-mouse Ab. Binding sites were detected with a Cy3-labeled goat anti-rabbit secondary Ab (red fluorescence). All sections were examined by confocal laser scanning microscopy. Background staining has been scanned in the green channel.
Immunofluorescent staining of TNFR1 and TNFR2 and subsequent confocal laser imaging of liver sections. Male BALB/c mice were treated with 20 mg/kg Con A. Livers were removed at the indicated time and stained with either anti-TNFR1 or anti-TNFR2 polyclonal rabbit anti-mouse Ab. Binding sites were detected with a Cy3-labeled goat anti-rabbit secondary Ab (red fluorescence). All sections were examined by confocal laser scanning microscopy. Background staining has been scanned in the green channel.
Determination of sTNFRs in the circulation of healthy mice by ELISA revealed that both receptors are continuously shed into the circulation (sTNFR1: 183 ± 78 pg/ml, sTNFR2: 2024 ± 63 pg/ml, cf Fig. 3). Con A injection induced a rapid increase of both sTNFRs in plasma, which parallels the decline that we observed by immunofluorescence (Fig. 3). We detected maximum levels of sTNFR1 (1354 ± 12 pg/ml; Fig. 3, solid line) and of sTNFR2 (5776 ± 769 pg/ml; Fig. 3, dotted line) 8 h after Con A injection. Thereafter, the levels of both soluble receptors declined slowly. Twenty-four hours after Con A injection the serum levels of both sTNFRs were still elevated. In comparison, TNF itself showed a sharp transient plasma peak with a maximum at 2 h after Con A injection (data not shown), as described previously (14).
Time course analysis of sTNF-R levels after Con A treatment. Male BALB/c mice were treated with 20 mg/kg Con A. Blood was taken by cardiac puncture at the indicated time. sTNFRs were determined by ELISA. Data are expressed as mean value ± SEM; n = 3 for each time point; ∗, p ≤ 0.05 vs saline control.
Time course analysis of sTNF-R levels after Con A treatment. Male BALB/c mice were treated with 20 mg/kg Con A. Blood was taken by cardiac puncture at the indicated time. sTNFRs were determined by ELISA. Data are expressed as mean value ± SEM; n = 3 for each time point; ∗, p ≤ 0.05 vs saline control.
In situ expression of ICAM-1, VCAM-1, and E-Selectin after Con A injection to wt mice
Before the investigation of the effect of TNFR deficiency on adhesion molecule expression in livers of Con A-treated mice, we analyzed their expression in wt mice. Immunofluorescent staining and subsequent confocal laser imaging revealed weak constitutive expression of ICAM-1 (Fig. 4,a) and VCAM-1 (Fig. 4,d) in livers of healthy mice, whereas no constitutive E-selectin (Fig. 4,g) and P-selectin (data not shown) expression was detectable. Time course analysis of the induction of adhesion molecule expression revealed a strong increase of ICAM-1 staining on sinusoids, central and portal veins as early as 6 h after challenge (data not shown), reaching high expression levels after 8–24 h (Fig. 4, b and c). VCAM-1 expression also started to increase after 6 h (data not shown), reaching highest expression 8 h after Con A injection (Fig. 4, e and f). Expression of E-selectin also increased as early as 6 h (data not shown) after Con A injection and was prominently expressed 8 h after challenge with staining of central and portal vein endothelial cells as well as of sinusoids (Fig. 4,h). Twenty-four hours after Con A, only minimal staining of E-selectin was detectable on postsinusoidal venules (Fig. 4 i). We failed to detect any staining of P-selectin in livers of Con A-treated mice (data not shown).
Immunofluorescent staining of ICAM-1, VCAM-1, E-selectin, and CD4 after Con A treatment. Male BALB/c mice were treated with 20 mg/kg Con A. Livers were removed at the indicated time points. Cryosections were performed at 10 μm and then stained with mAbs against either ICAM-1 (clone YN1/1.4.7) or VCAM-1 (clone MK2/1) or E-selectin (clone 10E9.6) or CD4 (clone RM4-5). Arrows indicate constitutive expression of ICAM-1 (a), VCAM-1 (d) and CD4+ T cells (j) in saline-treated mice. Primary mAbs were detected with goat anti-rat-IgG tagged with Texas Red.
Immunofluorescent staining of ICAM-1, VCAM-1, E-selectin, and CD4 after Con A treatment. Male BALB/c mice were treated with 20 mg/kg Con A. Livers were removed at the indicated time points. Cryosections were performed at 10 μm and then stained with mAbs against either ICAM-1 (clone YN1/1.4.7) or VCAM-1 (clone MK2/1) or E-selectin (clone 10E9.6) or CD4 (clone RM4-5). Arrows indicate constitutive expression of ICAM-1 (a), VCAM-1 (d) and CD4+ T cells (j) in saline-treated mice. Primary mAbs were detected with goat anti-rat-IgG tagged with Texas Red.
CD4+ T cell accumulation in the livers of Con A-treated mice
Immunofluorescent staining of the CD4 Ag revealed accumulation of CD4+ T cells as early as 6 h after Con A (data not shown). Eight hours (Fig. 4,k) after Con A injection, we found most of the CD4+ T cells in the hepatic parenchyma. Twenty-four hours after Con A, most of the CD4+ T cells were found as large cell clusters in the periportal region and almost no CD4+ T cells were detectable in the hepatic sinusoids (Fig. 4 L). These data are corroborated by the finding that 8 h after Con A injection, CD4+ T cell accumulation is induced 6.1 ± 1.2 (6.7 ± 1.3 × 105 CD4+/CD45+ cells) fold vs 1.0 ± 0.2 (1.1 ± 0.2 × 105 CD4+/CD45+cells) in saline-treated mice, as quantified by flow cytometric analysis of hepatic MNCs.
Expression of ICAM-1, VCAM-1, and E-Selectin in TNFR1−/− and TNFR2−/− mice treated with Con A
TNFR-deficient mice are resistant against Con A hepatitis. Therefore, we investigated whether deficiency in either one of both receptors alters the expression of adhesion molecules induced by Con A, thereby affecting the infiltration of the critical T cell population, i.e., CD4+ T cells, into hepatic tissue. To this end, we injected TNFR1−/−, TNFR2−/−, and corresponding wt mice (all three strains showed low constitutive ICAM-1 and VCAM-1 staining comparable to untreated BALB/c mice, cf Fig. 4, A and D) with Con A and analyzed the expression of ICAM-1, VCAM-1, and E-selectin 8 h after challenge. We failed to detect any difference in the staining intensity of ICAM-1 (Fig. 5, first column), VCAM-1 (Fig. 5, third column), or E-selectin (data not shown) between the TNFR-deficient and the corresponding wt mice. Accordingly, there was no difference in the accumulation of CD4+ T cells (data not shown).
TNF-induced ICAM-1 expression in the liver is under the control of TNFR1. Male TNFR1−/−, TNFR2−/−, or wt mice were either i.v.-injected with saline, 18 mg/kg Con A or 10 μg/kg rmuTNF. Livers were removed 8 h after treatment. Ten-micrometer cryosections were then stained with anti-ICAM-1 mAb (clone YN1/1.4.7) or anti-VCAM-1 mAb (clone MK211). Binding sites were detected with a Texas Red-conjugated secondary goat anti-rat Ab.
TNF-induced ICAM-1 expression in the liver is under the control of TNFR1. Male TNFR1−/−, TNFR2−/−, or wt mice were either i.v.-injected with saline, 18 mg/kg Con A or 10 μg/kg rmuTNF. Livers were removed 8 h after treatment. Ten-micrometer cryosections were then stained with anti-ICAM-1 mAb (clone YN1/1.4.7) or anti-VCAM-1 mAb (clone MK211). Binding sites were detected with a Texas Red-conjugated secondary goat anti-rat Ab.
ICAM-1 and VCAM-1 up-regulation by soluble recombinant TNF in the mouse liver is mediated by TNFR1
To further elucidate the role of TNF in up-regulating adhesion molecules in the liver, we injected TNFR1−/−, TNFR2−/− as well as wt mice with 10 μg/kg rmuTNF. Eight hours later, we removed the livers for immunofluorescent staining analysis of adhesion molecule expression. ICAM-1 (Fig. 5, second column) and VCAM-1 (Fig. 5, fourth column) expression was markedly induced in the livers of TNFR2−/− and wt mice, whereas no up-regulation was detectable in the livers of TNFR1−/− mice. We were unable to detect E-selectin in the livers of TNF-treated TNFR1−/−, TNFR2−/−, and wt mice, respectively, most likely reflecting the fact that the concentration of rmuTNF used was not sufficient to induce E-selectin expression in the liver.
These results clearly demonstrate that TNF-mediated ICAM-1 as well as VCAM-1 up-regulation in the liver is under the control of the TNFR1.
Functional role of adhesion molecules in Con A hepatitis
To elucidate the functional role of the different adhesion molecules and their counterparts on leukocytes, we performed in vivo blocking studies, using mAbs against either ICAM-1/LFA-1 or VCAM-1 or E-selectin or P-selectin. But surprisingly, despite the strong expression of the adhesion receptors (see above), none of these Abs given either alone, i.e., anti-VCAM-1, anti-ICAM-1/anti-LFA-1, anti-E-selectin, anti-P-selectin (data not shown), or in combination (cf Fig. 6), or gene-targeted deletion of ICAM-1 (data not shown), prevented the development of acute hepatic failure induced by Con A. Plasma ALT levels were unaltered in normal mice passively immunized against E-selectin and P-selectin (Fig. 6,A) or in ICAM−/− mice treated with anti-VCAM-1 mAb before Con A injection (Fig. 6,B) compared with Con A controls pretreated with a control IgG Ab. Moreover, the production of the central mediators TNF and INF-γ as well as of IL-2 was not affected (data not shown). However, flow cytometric analysis of isolated hepatic MNCs revealed that either anti-E-selectin mAb injection (Fig. 7,A) or the use of ICAM-1−/− mice treated with anti-VCAM-1 mAb (Fig. 7 B) before Con A treatment significantly reduced total accumulation of CD4+ T cells ∼45 and 55%, respectively, compared with control mAb pretreated mice. In contrast, pretreatment of mice with either anti-ICAM-1 or anti-VCAM-1 mAb alone insignificantly inhibited total Con A-induced accumulation of CD4+ T cells by 20% (data not shown).
In vivo blockade of adhesion molecules failed to prevent Con A-induced hepatic failure. A, Male BALB/c mice were injected with 200 μg of anti-E-selectin (anti-ES, clone UZ4) together with 200 μg anti-P-selectin (anti-PS, clone RB40.34) 15 min before injection of 20 mg/kg Con A. In the control group, mice received a control Ab (control mAb, clone BR2), which does not interact with adhesion molecules. B, ICAM-1−/− mice were i.v.-injected with 200 μg of anti-VCAM-1 mAb (clone 429) 15 min before Con A application. In all groups, mice were sacrificed 8 h after either Con A or saline treatment and blood was taken by cardiac puncture. For determination of liver damage, we performed ALT measurement. Data are expressed as mean values ± SEM; n = 3 per group.
In vivo blockade of adhesion molecules failed to prevent Con A-induced hepatic failure. A, Male BALB/c mice were injected with 200 μg of anti-E-selectin (anti-ES, clone UZ4) together with 200 μg anti-P-selectin (anti-PS, clone RB40.34) 15 min before injection of 20 mg/kg Con A. In the control group, mice received a control Ab (control mAb, clone BR2), which does not interact with adhesion molecules. B, ICAM-1−/− mice were i.v.-injected with 200 μg of anti-VCAM-1 mAb (clone 429) 15 min before Con A application. In all groups, mice were sacrificed 8 h after either Con A or saline treatment and blood was taken by cardiac puncture. For determination of liver damage, we performed ALT measurement. Data are expressed as mean values ± SEM; n = 3 per group.
E-selectin and ICAM-1 together with VCAM-1 contribute to hepatic CD4+ T cell accumulation induced by Con A. Male BALB/c mice were either pretreated with a control mAb (BR2) or anti-E-selectin (A) before Con A-injection. If ICAM-1−/− mice were used (B), the corresponding Bl6 × 129 wt mice were taken as control. Wt mice were i.v.-injected with either control mAb or with anti VCAM-1 mAb before Con A treatment, which insignificantly reduced CD4+ T cell infiltration by 20% (data not shown). ICAM-1−/− mice treated with Con A also displayed an insignificant reduction of CD4+ T cell infiltration of ∼20% vs Con A-injected wt mice (data not shown). The results presented in (B) demonstrate that treatment of ICAM-1−/− mice with anti-VCAM-1 mAb before Con A significantly inhibited CD4+ T cell accumulation vs wt mice treated with the control mAb and Con A. To quantify total CD4+ T cells per liver, we isolated hepatic MNCs (cf Materials and Methods) 8 h after treatment and subsequently performed flow cytometer analysis after double staining of the MNCs with anti-CD45 and anti-CD4 mAb. CD4+ T cell percentage of total leukocytes was calculated by multiplication of the percentage of CD4+ cells with the percentage of CD45+, which was then multiplied with the number of total isolated MNCs to achieve the absolute cell number. The total number of CD4+ T cells in saline-treated mice was set to 1 for each individual experiment. Data are expressed as mean value ± SEM of x-fold induction of CD4+ T cell accumulation vs saline-treated control animals. n = 4 per group; ∗, p ≤ 0.05 vs the corresponding control mAb pretreated, Con A-injected group.
E-selectin and ICAM-1 together with VCAM-1 contribute to hepatic CD4+ T cell accumulation induced by Con A. Male BALB/c mice were either pretreated with a control mAb (BR2) or anti-E-selectin (A) before Con A-injection. If ICAM-1−/− mice were used (B), the corresponding Bl6 × 129 wt mice were taken as control. Wt mice were i.v.-injected with either control mAb or with anti VCAM-1 mAb before Con A treatment, which insignificantly reduced CD4+ T cell infiltration by 20% (data not shown). ICAM-1−/− mice treated with Con A also displayed an insignificant reduction of CD4+ T cell infiltration of ∼20% vs Con A-injected wt mice (data not shown). The results presented in (B) demonstrate that treatment of ICAM-1−/− mice with anti-VCAM-1 mAb before Con A significantly inhibited CD4+ T cell accumulation vs wt mice treated with the control mAb and Con A. To quantify total CD4+ T cells per liver, we isolated hepatic MNCs (cf Materials and Methods) 8 h after treatment and subsequently performed flow cytometer analysis after double staining of the MNCs with anti-CD45 and anti-CD4 mAb. CD4+ T cell percentage of total leukocytes was calculated by multiplication of the percentage of CD4+ cells with the percentage of CD45+, which was then multiplied with the number of total isolated MNCs to achieve the absolute cell number. The total number of CD4+ T cells in saline-treated mice was set to 1 for each individual experiment. Data are expressed as mean value ± SEM of x-fold induction of CD4+ T cell accumulation vs saline-treated control animals. n = 4 per group; ∗, p ≤ 0.05 vs the corresponding control mAb pretreated, Con A-injected group.
Discussion
Inflammatory diseases, such as viral hepatitis (8, 9, 11) or hepatic inflammation due to alcohol abuse (10), are associated with enhanced sTNFR serum levels, as well as with a strong up-regulation of both TNFRs in situ. But, up to now, only a few experimental data exist concerning the in vivo regulation and function of TNFR1 and TNFR2 under conditions of acute inflammation.
It has been shown previously that TNFR1 and TNFR2 mRNA was rapidly induced in livers of mice suffering from TNF-dependent, carbon tetrachloride-induced liver damage (27). In contrast, in the Con A model, where liver injury depends on both TNFRs (16), we did not observe a transcriptional regulation of hepatic TNFR1 and TNFR2 mRNA, although both transcripts were significantly induced in the spleen within the same time-span after Con A injection. However, we observed a profound reduction of TNFR1 and TNFR2 expression in liver sections after Con A injection. This down-regulation is paralleled by a marked increase in both sTNFR serum levels. Elevated serum levels of soluble TNFRs, especially TNFR2 have often been described to correlate with TNF serum levels and disease activity in acute and chronic liver disease (i.e., hepatitis B or C or autoimmunohepatitis) in humans (8, 9, 11, 28, 29), which might point to a desensitizing mechanism, that protects hepatocytes from the high local levels of TNF. The contradictory observations between carbon tetrachloride- and Con A-induced liver injury are not yet clear, but it seems likely that the T cell mitogen Con A induces a different local cytokine milieu, thereby inducing a distinct transcriptional regulation of TNFR mRNA expression in hepatic tissue.
Leukocyte recruitment from the blood stream is a central feature of inflammatory responses, which is regulated by adhesion molecules expressed on endothelial cells and their counter receptors on leukocytes (2). Because expression of these adhesion molecules is induced during inflammation, we analyzed their expression pattern after Con A application. We found that, in contrast to selectins, ICAM-1 and VCAM-1 were constitutively expressed, which is in line with earlier reports. Upon Con A injection, a massive induction of hepatic ICAM-1, VCAM-1, and E-selectin expression was seen. This induction of adhesion molecules corroborates earlier reports showing an up-regulation of ICAM-1, VCAM-1, and E-selectin in the liver under inflammatory conditions in humans (30) and mice (31, 32). However, others described a lack of inducibility of selectins in human livers and excluded a role for selectin-mediated leukocyte recruitment via hepatic sinusoids (33, 34). Hence, the data concerning selectin expression and their functional role for leukocyte recruitment in liver microvasculature still remain to be elucidated. But one can conceive that selectin-mediated rolling mechanisms in hepatic sinusoids are not necessary for leukocyte endothelial interaction, because of the slow blood flow that allows continuous contact between leukocytes and endothelial cells.
TNF is well known as a potent inducer of several adhesion molecules. Hence, we wondered whether mice deficient in either one of both TNFRs would exhibit a different pattern of adhesion molecule expression after Con A treatment. However, we could not find any difference between Con A-treated TNFR1−/−, TNFR2−/− mice, and the corresponding wt animals. Moreover CD4+ T cell infiltration was unaltered in TNFR−/− mice compared with the wt. These findings implicate that the resistance of TNFR−/− mice toward Con A was not due to an impaired induction of adhesion molecules by TNF. In contrast, a resistance of TNFR2−/− mice against experimentally induced acute cerebral malaria, which resulted from a lack of mTNF-inducible ICAM-1 expression, was recently described by Lucas et al. (7). However, treatment with rmuTNF instead of Con A induced ICAM-1 and VCAM-1 only in TNFR2−/− and wt mice, but not in TNFR1−/− mice. Hence, our data provide evidence that ICAM-1 expression in the liver is exclusively under the control of TNFR1. These findings corroborate previous findings showing that in other cell systems and tissues, TNF-inducible adhesion molecule expression including ICAM-1 and VCAM-1 is mediated by TNFR1 (35, 36). The observation that Con A-treated TNFR−/− mice express high levels of adhesion molecules, although TNF-induced expression of adhesion molecules in the liver is under control of TNFR1 suggest the involvement of other endothelium activating cytokines such as IL-1, IL-12, or IFN-γ (37, 38).
However, it remained unclear whether these adhesion molecules take part in the hepatic accumulation of activated CD4+ T cells, i.e., the critical cell population in this experimental model (15). In this study we provide evidence that although CD4+ T cell accumulation was significantly inhibited by blockade of E-selectin or by lack of ICAM-1 together with VCAM-1 blockade, these adhesion molecules play no functional role for the onset of liver disease induced by Con A. This is in contrast to previous reports describing inhibitory effects of either anti-E-selectin and anti-VCAM-1 mAb (39) or anti-ICAM-1 mAb but not anti-VCAM-1 mAb (18). These controversial findings might have been due to different pretreatment regiments, e.g., Ab pretreatment 24 and 48 h before Con A injection, which might have depleted intrahepatic lymphocytes critical for the development of liver injury. In contrast, in our study, we have pretreated mice with the respective Abs shortly before Con A administration and the pretreatment regiment was proven to be functional with respect to a significant inhibition of CD4+ T cell accumulation. Interestingly, accumulation of CD4+ T cells in hepatic sinusoids remained unaffected by blockade of adhesion molecules (data not shown). Hence, E-selectin, ICAM-1, and VCAM-1 contributed to CD4+ T cell recruitment via pre- and postsinusoidal veins, whereas accumulation of CD4+ T cells in sinusoids seems to be regulated differently. The findings that adhesion molecules were strongly expressed and that the accumulation of CD4+ T cells was partially inhibited by adhesion molecule blockade, whereas the development of liver disease remained unaffected, was surprising, because CD4+ T cells have been shown to be critical for the development of Con A hepatitis by Ab-dependent depletion of CD4+ T cells (15). It is conceivable that this procedure also depleted the CD4+ proportion of liver resident Vα14 NK T cells, which have been shown to be central for the onset of Con A-induced liver disease (40, 41, 42). Hence, it seems likely that Con A-induced stimulation of local immune cells, i.e., NK T cells in concert with thymus derived T cells, which have been shown to be abundant in the parenchymal space (43), and liver resident macrophages are sufficient to induce hepatocellular damage. Recruitment of CD4+ T cells from the circulation may then contribute to the elimination of harmful activated intrahepatic lymphocytes (i.e., T cells, NK T cells, or NK cells) (44). Hence, blocking ICAM-1, VCAM-1, or E-selectin as therapeutic approach to inhibit human liver disease has to be carefully considered.
Acknowledgements
We thank Dr. H. Bluethmann (F. Hoffmann-LaRoche AG, Basle, Switzerland) for kindly providing us TNFR knockout mice. We are indebted to Dr. G. R. Adolf (Bender & Co Vienna, Austria) for providing recombinant murine TNF. We are also indebted to Dr. D. Vestweber for providing anti-P-selectin mAb (23). We thank Dr. W. Neuhuber (Institute of Anatomy, University of Erlangen-Nürnberg, Erlangen, Germany) for experimental support regarding confocal laser scanning microscopy. The perfect technical assistance of Andrea Agli is gratefully acknowledged.
Footnotes
This work was supported by the Deutsche Forschungsgemeinschaft, Grants Ti 169/4-2 and Ti 169/4-3.
Abbreviations used in this paper: m, membrane-bound; s, soluble; wt, wild type; mu, murine; ALT, alanine aminotransferase; MNC, mononuclear cell.